Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
18.79
-0.22 (-1.16%)
Apr 29, 2026, 10:28 AM EDT - Market open
Monte Rosa Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,503 | 1,021 | 426 | 283 | 368 | 950 | |
| Market Cap Growth | 479.22% | 139.48% | 50.74% | -23.21% | -61.22% | - | |
| Enterprise Value | 1,183 | 670 | 228 | 151 | 142 | 583 | |
| Last Close Price | 19.01 | 15.68 | 6.94 | 5.65 | 7.61 | 20.42 | |
| PS Ratio | 12.30 | 8.26 | 5.64 | - | - | - | |
| PB Ratio | 5.35 | 4.38 | 1.91 | 1.58 | 1.36 | 2.73 | |
| P/TBV Ratio | 6.53 | 4.38 | 1.91 | 1.58 | 1.36 | 2.73 | |
| P/FCF Ratio | - | - | 11.22 | - | - | - | |
| P/OCF Ratio | - | - | 10.15 | - | - | - | |
| EV/Sales Ratio | 9.57 | 5.42 | 3.01 | - | - | - | |
| EV/FCF Ratio | - | - | 6.00 | - | - | - | |
| Debt / Equity Ratio | 0.17 | 0.17 | 0.19 | 0.26 | 0.17 | - | |
| Debt / FCF Ratio | - | - | 1.12 | - | - | - | |
| Net Debt / Equity Ratio | -1.45 | -1.45 | -1.48 | -1.04 | -0.79 | -1.00 | |
| Net Debt / EBITDA Ratio | 7.37 | 7.37 | 4.51 | 1.36 | 1.99 | 4.89 | |
| Net Debt / FCF Ratio | 12.29 | 12.29 | -8.67 | 2.97 | 2.05 | 5.01 | |
| Asset Turnover | 0.28 | 0.28 | 0.20 | - | - | - | |
| Quick Ratio | 6.05 | 6.05 | 2.37 | 5.00 | 10.58 | 20.80 | |
| Current Ratio | 6.12 | 6.12 | 2.40 | 5.07 | 10.79 | 20.96 | |
| Return on Equity (ROE) | -16.94% | -16.94% | -36.15% | -60.07% | -35.06% | -40.35% | |
| Return on Assets (ROA) | -7.64% | -7.64% | -13.66% | -27.72% | -19.82% | -21.92% | |
| Return on Capital Employed (ROCE) | -14.10% | -14.10% | -28.80% | -55.70% | -35.50% | -20.80% | |
| Earnings Yield | -2.54% | -3.78% | -17.05% | -47.85% | -29.46% | -7.79% | |
| FCF Yield | -1.81% | -2.69% | 8.91% | -22.22% | -28.61% | -7.28% | |
| Buyback Yield / Dilution | -12.39% | -12.39% | -43.80% | -8.83% | -88.91% | -1548.09% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.